Movement of Haemophilus influenzae types resistance isolated from sputum in patients with COPD in 2004 Source: Eur Respir J 2005; 26: Suppl. 49, 60s Year: 2005
HI-164, an oral vaccine to non-typable haemophilus influenzae , reduces antibiotic use, respiratory exacerbations and hospitalisations in patients with COPD Source: Annual Congress 2007 - Different aspects of COPD exacerbations Year: 2007
The impact of antibiotic resistance in the management of lower respiratory tract infections Source: ISSN=1025-448x, ISBN=1-904097-32-4, page=131 Year: 2004
Airway abundance of Haemophilus influenzae predicts response to azithromycin in adults with persistent uncontrolled asthma Source: Eur Respir J, 56 (4) 2000194; 10.1183/13993003.00194-2020 Year: 2020
Macrolides, quinolones and amoxicillin/clavulanate for chronic bronchitis: a meta-analysis Source: Eur Respir J 2007; 29: 1127-1137 Year: 2007
Specific immune response against pseudomonas aeruginosa and haemophilus influenzae in severe COPD Source: International Congress 2016 – Clinical and microbiological aspects of infections in COPD patients Year: 2016
Clinical impact of a non-typeable Haemophilus influenzae (NTHi) adjuvanted vaccine in adults with chronic obstructive pulmonary disease (COPD) Source: International Congress 2019 – COPD clinical trials: new molecules and novel insights Year: 2019
Infection pattern and inflammatory response in acute and persistent nontypeable haemophilus influenzae (NTHi) infection of COPD lung tissue Source: Eur Respir J 2006; 28: Suppl. 50, 841s Year: 2006
Microbiological efficacy of combined use of vaccines against S. pneumoniae, H. influenzae type B in patients with a COPD Source: Annual Congress 2011 - Role of infection in exacerbations of COPD Year: 2011
Associations between haemophilus influenzae and levels of sputum antimicrobial peptides in COPD Source: International Congress 2016 – Translational research in respiratory infections Year: 2016
Haemophilus influenzae persists in biofilm communities in a smoke-exposed ferret model of COPDSource: ERJ Open Res, 6 (3) 00200-2020; 10.1183/23120541.00200-2020 Year: 2020
Increased uptake of haemophilus influenzae by primary airway epithelial cells from COPD patients Source: International Congress 2016 – New signalling pathways in COPD Year: 2016
Antibiotic resistance of Streptococcus pneumoniae and Haemophilus influenzae strains isolated from community-aquired inferior respiratory tract infections in Romania Source: Eur Respir J 2001; 18: Suppl. 33, 140s Year: 2001
Impaired serum opsonisation of non typeable Haemophilus influenzae in COPD and Alpha-1 Anti-Trypsin Deficiency. A potential mechanism for reduced bacterial clearance? Source: International Congress 2017 – Infection and exacerbation science Year: 2017
Pseudomonas aeruginosa drug susceptibility in patients hospitalized with COPD exacerbation and bronchiectasisSource: Eur Respir J 2001; 18: Suppl. 33, 541s Year: 2001
Non-typeable Haemophilus influenzae infection of ciliated epithelium from healthy and chronic obstructive pulmonary disease donors Source: International Congress 2018 – The airway microbiome across the spectrum of airway disease Year: 2018
Chronic bronchial infection/colonisation: aetiology and mechanisms Source: Eur Respir Monogr 2013; 60: 34-45 Year: 2013
Streptococcus pneumoniae resistance pattern and its clinical implicationsSource: Annual Congress 2006 - PG1 - Respiratory infections: pneumonia/antibiotic resistance and clinical outcome of lower respiratory tract infections Year: 2006
Prevalence of erythromycin resistance in lower airway bacterial isolates from patients with stable COPD Source: Eur Respir J 2005; 26: Suppl. 49, 251s Year: 2005
The role of Moraxella catarrhalis in COPD Source: Annual Congress 2005 - COPD: role of infection Year: 2005